Literature DB >> 21733821

Role of autophagy in cancer prevention.

Hsin-Yi Chen1, Eileen White.   

Abstract

Macroautophagy (autophagy hereafter) is a catabolic process by which cells degrade intracellular components in lysosomes. This cellular garbage disposal and intracellular recycling system maintains cellular homeostasis by eliminating superfluous or damaged proteins and organelles and invading microbes and by providing substrates for energy generation and biosynthesis in stress. Autophagy thus promotes the health of cells and animals and is critical for the development, differentiation, and maintenance of cell function and for the host defense against pathogens. Deregulation of autophagy is linked to susceptibility to various disorders including degenerative diseases, metabolic syndrome, aging, infectious diseases, and cancer. Autophagic activity emerges as a critical factor in the development and progression of diseases that are associated with increased cancer risk as well as in different stages of cancer. Given that cancer is a complex process and autophagy exerts its effects in multiple ways, the role of autophagy in tumorigenesis is context-dependent. As a cytoprotective survival pathway, autophagy prevents chronic tissue damage that can lead to cancer initiation and progression. In this setting, stimulation or restoration of autophagy may prevent cancer. In contrast, once cancer occurs, many cancer cells upregulate basal autophagy and utilize autophagy to enhance fitness and survive in the hostile tumor microenvironment. These findings revealed the concept that aggressive cancers can be addicted to autophagy for survival. In this setting, autophagy inhibition is a therapeutic strategy for established cancers.

Entities:  

Mesh:

Year:  2011        PMID: 21733821      PMCID: PMC3136921          DOI: 10.1158/1940-6207.CAPR-10-0387

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  77 in total

1.  p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription.

Authors:  Ashish Jain; Trond Lamark; Eva Sjøttem; Kenneth Bowitz Larsen; Jane Atesoh Awuh; Aud Øvervatn; Michael McMahon; John D Hayes; Terje Johansen
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62.

Authors:  Alexandria Lau; Xiao-Jun Wang; Fei Zhao; Nicole F Villeneuve; Tongde Wu; Tao Jiang; Zheng Sun; Eileen White; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

Review 3.  Metformin in cancer therapy: a new perspective for an old antidiabetic drug?

Authors:  Issam Ben Sahra; Yannick Le Marchand-Brustel; Jean-François Tanti; Frédéric Bost
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

4.  An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.

Authors:  Tunda Hidvegi; Michael Ewing; Pamela Hale; Christine Dippold; Caroline Beckett; Carolyn Kemp; Nicholas Maurice; Amitava Mukherjee; Christina Goldbach; Simon Watkins; George Michalopoulos; David H Perlmutter
Journal:  Science       Date:  2010-06-03       Impact factor: 47.728

5.  Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.

Authors:  Yasemin Sancak; Liron Bar-Peled; Roberto Zoncu; Andrew L Markhard; Shigeyuki Nada; David M Sabatini
Journal:  Cell       Date:  2010-04-08       Impact factor: 41.582

6.  Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations.

Authors:  Ju-Hyun Lee; W Haung Yu; Asok Kumar; Sooyeon Lee; Panaiyur S Mohan; Corrinne M Peterhoff; Devin M Wolfe; Marta Martinez-Vicente; Ashish C Massey; Guy Sovak; Yasuo Uchiyama; David Westaway; Ana Maria Cuervo; Ralph A Nixon
Journal:  Cell       Date:  2010-06-10       Impact factor: 41.582

Review 7.  Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer.

Authors:  S Danese; A Mantovani
Journal:  Oncogene       Date:  2010-04-19       Impact factor: 9.867

8.  Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine.

Authors:  Ken Cadwell; Khushbu K Patel; Nicole S Maloney; Ta-Chiang Liu; Aylwin C Y Ng; Chad E Storer; Richard D Head; Ramnik Xavier; Thaddeus S Stappenbeck; Herbert W Virgin
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

9.  Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.

Authors:  Ling Yang; Ping Li; Suneng Fu; Ediz S Calay; Gökhan S Hotamisligil
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

10.  Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease.

Authors:  Claudia Rose; Fiona M Menzies; Maurizio Renna; Abraham Acevedo-Arozena; Silvia Corrochano; Oana Sadiq; Steve D Brown; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-02-27       Impact factor: 6.150

View more
  72 in total

Review 1.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

Review 2.  Deconvoluting the context-dependent role for autophagy in cancer.

Authors:  Eileen White
Journal:  Nat Rev Cancer       Date:  2012-04-26       Impact factor: 60.716

Review 3.  Liver autophagy: much more than just taking out the trash.

Authors:  Jaime L Schneider; Ana Maria Cuervo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-11-05       Impact factor: 46.802

4.  A cancer associated somatic mutation in LC3B attenuates its binding to E1-like ATG7 protein and subsequent lipidation.

Authors:  Gal Chaim Nuta; Yuval Gilad; Moran Gershoni; Arielle Sznajderman; Tomer Schlesinger; Shani Bialik; Miriam Eisenstein; Shmuel Pietrokovski; Adi Kimchi
Journal:  Autophagy       Date:  2018-10-08       Impact factor: 16.016

Review 5.  Targeting autophagy in cancer.

Authors:  Jean M Mulcahy Levy; Christina G Towers; Andrew Thorburn
Journal:  Nat Rev Cancer       Date:  2017-07-28       Impact factor: 60.716

Review 6.  hERG1 potassium channel in cancer cells: a tool to reprogram immortality.

Authors:  Saverio Gentile
Journal:  Eur Biophys J       Date:  2016-09-20       Impact factor: 1.733

7.  The transcription factor GATA3 is required for homologous recombination repair by regulating CtIP expression.

Authors:  F Zhang; H Tang; Y Jiang; Z Mao
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

8.  Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis- and autophagy-regulating molecules.

Authors:  Pallavi Banerjee; Aninda Basu; Barbara Wegiel; Leo E Otterbein; Kenji Mizumura; Martin Gasser; Ana Maria Waaga-Gasser; Augustine M Choi; Soumitro Pal
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

9.  Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor.

Authors:  Virendra K Chaudhri; Gregory G Salzler; Salihah A Dick; Melanie S Buckman; Raffaella Sordella; Edward D Karoly; Robert Mohney; Brendon M Stiles; Olivier Elemento; Nasser K Altorki; Timothy E McGraw
Journal:  Mol Cancer Res       Date:  2013-03-08       Impact factor: 5.852

Review 10.  Regulation of autophagy by mitochondrial phospholipids in health and diseases.

Authors:  Paul Hsu; Yuguang Shi
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-08-05       Impact factor: 4.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.